Skip to content

Obstructive Sleep Apnea in Pulmonary Embolism

Obstructive Sleep Apnea is Prevalent in Patients With Pulmonary Embolism

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01580085
Enrollment
75
Registered
2012-04-18
Start date
2009-11-30
Completion date
2010-12-31
Last updated
2012-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obstructive Sleep Apnea, Pulmonary Thromboembolism

Keywords

Sleep disordered breathing, gender, hypercoagulability

Brief summary

Obstructive sleep apnea (OSA) is a clinical syndrome characterized by repetitive closure of the airway and frequent awakenings during sleep. Repeated episodes of hypoxia, decrease in intrathoracic pressure, increased venous return and venous stasis, damage to vascular wall may ensue. An increased tendency for coagulation has also been reported in OSA. Venous stasis, vascular endothelial activation and hypercoagulability are also known risk factors for thromboembolism. All of these pathophysiologic changes in OSA may predispose patients for the development of pulmonary embolism (PE) however there is limited data about role of thromboembolic events in OSA.

Interventions

OTHERpolysomnography

full night supervised laboratory polysomnography

Sponsors

University of Gaziantep
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* All consecutive patients diagnosed with pulmonary embolism

Exclusion criteria

* less than 18 years of age * any restrictive or obstructive lung disease

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026